<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ataxin-3 (ATXN3), the disease protein in spinocerebellar <z:hpo ids='HP_0001251'>ataxia</z:hpo> type 3 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>), binds to target gene promoters and modulates transcription by interaction with transcriptional regulators </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we show that ATXN3 interacts with the forkhead box O (FOXO) transcription factor FOXO4 and activates the FOXO4-dependent transcription of the <z:chebi fb="70" ids="18291,35154">manganese</z:chebi> <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (SOD2) gene </plain></SENT>
<SENT sid="2" pm="."><plain>Upon <z:mp ids='MP_0003674'>oxidative stress</z:mp>, ATXN3 and FOXO4 translocate to the nucleus, concomitantly bind to the SOD2 gene promoter and increase the expression of the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzyme SOD2 </plain></SENT>
<SENT sid="3" pm="."><plain>Compared with <z:mpath ids='MPATH_458'>normal</z:mpath> ATXN3, mutant ATXN3 has a reduced capability to activate the FOXO4-mediated SOD2 expression and interferes with binding of FOXO4 to the SOD2 gene promoter </plain></SENT>
<SENT sid="4" pm="."><plain>These findings are consistent with a downregulation of SOD2 in pontine brain tissue and lymphoblastoid cell (LC) lines of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> patients </plain></SENT>
<SENT sid="5" pm="."><plain>In response to <z:mp ids='MP_0003674'>oxidative stress</z:mp>, LCs from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> patients show a specific impairment to upregulate SOD2 expression in correlation with a significantly increased formation of reactive oxygen species and cytotoxicity </plain></SENT>
<SENT sid="6" pm="."><plain>The impairment to increase the expression of SOD2 under <z:mp ids='MP_0003674'>oxidative stress</z:mp> conditions is associated with a significantly reduced binding of FOXO4 to the SOD2 gene promoter in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>-LCs </plain></SENT>
<SENT sid="7" pm="."><plain>Finally and consistent with a regulatory role of ATXN3 in SOD2 expression, knockdown of endogenous ATXN3 by <z:chebi fb="40" ids="33697">RNA</z:chebi> interference represses the expression of SOD2 </plain></SENT>
<SENT sid="8" pm="."><plain>These findings support that ATXN3 plays an important role in regulating the FOXO4-dependent <z:chebi fb="11" ids="22586">antioxidant</z:chebi> stress response via SOD2 and suggest that a decreased antioxidative capacity and increased susceptibility towards <z:mp ids='MP_0003674'>oxidative stress</z:mp> contributes to neuronal cell <z:hpo ids='HP_0011420'>death</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> </plain></SENT>
</text></document>